Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Cash from Investing Activities (2022 - 2025)

Historic Cash from Investing Activities for Lucid Diagnostics (LUCD) over the last 4 years, with Q3 2025 value amounting to -$28000.0.

  • Lucid Diagnostics' Cash from Investing Activities rose 9200.0% to -$28000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$405000.0, marking a year-over-year increase of 2793.59%. This contributed to the annual value of -$646000.0 for FY2024, which is 19230.77% down from last year.
  • According to the latest figures from Q3 2025, Lucid Diagnostics' Cash from Investing Activities is -$28000.0, which was up 9200.0% from -$25000.0 recorded in Q2 2025.
  • Lucid Diagnostics' Cash from Investing Activities' 5-year high stood at -$14000.0 during Q3 2023, with a 5-year trough of -$2.4 million in Q2 2022.
  • In the last 4 years, Lucid Diagnostics' Cash from Investing Activities had a median value of -$120500.0 in 2022 and averaged -$365785.7.
  • In the last 5 years, Lucid Diagnostics' Cash from Investing Activities skyrocketed by 9938.42% in 2023 and then crashed by 240000.0% in 2024.
  • Lucid Diagnostics' Cash from Investing Activities (Quarter) stood at -$203000.0 in 2022, then increased by 13.79% to -$175000.0 in 2023, then tumbled by 48.0% to -$259000.0 in 2024, then soared by 89.19% to -$28000.0 in 2025.
  • Its Cash from Investing Activities was -$28000.0 in Q3 2025, compared to -$25000.0 in Q2 2025 and -$93000.0 in Q1 2025.